News

Accuray Revolutionizes Cancer Treatment with Advanced Technology

Accuray Revolutionizes Cancer Treatment with Advanced Technology

Accuray advances precision in cancer care

Accuray Incorporated (NASDAQ: ARAY) is pushing radiation therapy forward with its Radixact® Radiation Delivery System and the VitalHold™ solution. Working with the Gifu Prefectural General Medical Center, the company has helped bring surface-guided radiation therapy (SGRT) to clinical practice in Japan. The goal is simple and concrete: make every treatment more precise, more consistent, and more protective of healthy tissue—one patient at a time.

Why precision matters in radiation therapy

Radiation therapy is a cornerstone of cancer care. About half of all people diagnosed with cancer will need it at some point in their treatment. Accuray’s technology is designed to sharpen that care—improving accuracy and consistency when millimeters matter. That’s especially important for approaches like deep inspiration breath hold (DIBH), which can create space between the tumor and critical organs. In breast cancer care, for example, DIBH can help protect the heart while still allowing the radiation dose to reach the intended target.

How SGRT supports accurate setup and delivery

At Gifu, SGRT uses high?resolution cameras to watch the patient’s breathing and position in real time. The system continuously tracks the skin surface and builds a detailed 3D map unique to each person. With that live map, the care team can confirm alignment at the exact moment radiation is delivered, helping reduce setup uncertainty and improving confidence throughout treatment.

Improving day-to-day care with modern tools

Sandeep Chalke, Senior Vice President and interim CEO at Accuray, underscored the company’s pride in collaborating with Gifu Prefectural General Medical Center. He highlighted the role the Radixact System and VitalHold technology can play in elevating cancer care in Japan—supporting clinicians with tools that are built for precision and designed for everyday use.

What clinicians are seeing in practice

Dr. Yuichi Kajiura from the Department of Radiation Oncology at Gifu described the hospital’s transition from an older C?arm linear accelerator to the Radixact System. The differences stand out: faster patient setup and stronger monitoring during treatment. By tightening up the workflow and improving how patients are tracked, the team can deliver precise, high?quality therapies tailored to each person’s plan without adding unnecessary steps.

Key capabilities that support precision

ClearRT™ imaging is a central feature. It provides clearer views that help clinicians see changes in tumor shape and configuration over the course of therapy. Better visibility supports more accurate alignment and delivery, which is critical when adapting to day?to?day differences in how a patient presents for treatment. Precision in imaging feeds precision in care.

A steady focus on safety and innovation

Safety is the throughline in Accuray’s work. The company continues to invest in research and product improvements with the intent to bring practical, market?changing solutions to clinics. The aim remains steady: advance technology that helps clinicians deliver effective treatments while improving the experience and outcomes for people living with cancer.

About Accuray

Headquartered in Sunnyvale, California, Accuray develops radiation therapy technologies focused on accuracy and reliability. The company works closely with healthcare providers to expand what’s possible in cancer care, guided by a mission to deliver meaningful value to patients and the teams who treat them.

Contact information

To learn more about Accuray and its radiation therapy solutions, interested parties can contact the company’s Public Relations Department. Accuray remains committed to supporting advances in treatment methods and to improving patient access to critical radiation therapies across care settings.

Frequently Asked Questions

What is the Radixact System, in plain terms?

It’s a radiation delivery system built to make treatments more precise and consistent, especially when plans are complex and target areas are close to sensitive organs.

How does VitalHold fit into a patient’s treatment?

VitalHold is designed to help maintain accurate patient positioning during radiation, supporting techniques like breath hold so the dose goes where it’s intended while limiting exposure to healthy tissue.

What makes surface?guided radiation therapy (SGRT) useful?

SGRT tracks the patient’s skin surface in real time with cameras, giving the care team a live 3D reference to confirm alignment and manage motion throughout treatment.

How does ClearRT imaging help the clinical team?

ClearRT provides clearer images that help clinicians see and assess changes in tumor shape and configuration during a course of care, which supports accurate alignment and delivery each day.

Where is Accuray based, and how can I get in touch?

Accuray is headquartered in Sunnyvale, California. For details about its cancer treatment solutions, you can reach out to the company’s Public Relations Department.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 143

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 132

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 150

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 53

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
55 Broad Street's New Face: A $500M Revamp with RXR

Updated Category News Views 189

Recapitalization: Changing the Game for 55 Broad Street Here we are again, watching yet another iconic Manhattan building redefine itself. This time, it's 55 Broad Street's turn, as Silverstein, MetroLoft, and RXR shake things up. Newmark Group, Inc. (NASDAQ: NMRK), the fiery real estate power player, orchestrated a dynamic transaction involving a $305 million financing...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 107

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

Padlock Euro Storage Fund I Unveils Fourth-Quarter Distributions

Updated Category News Views 171

Padlock Euro Storage Fund I Distributions for Q4 2024 Padlock Euro Storage Fund I has recently shared good news for its unitholders regarding the cash distribution for the fourth quarter of the calendar year. The board of Trustees has officially approved these distributions, which reflect the Trust’s performance and commitment to its investors. Distribution Details The...

Continue Reading
Deer Park Road Seizes Opportunities Amid Commercial Real Estate Shift

Updated Category News Views 264

Deer Park Road's Strategic Focus on the CRE Market Deer Park Road Management Company, with a robust portfolio of $2.8 billion in alternative asset management, is navigating the turbulent waters of the commercial real estate (CRE) market. While challenges persist, especially in the Commercial Mortgage-Backed Securities (CMBS) sector, the firm sees compelling opportunities...

Continue Reading
MCB Real Estate's Rejection of Whitestone Offer Sparks Debate

Updated Category News Views 76

MCB Real Estate's Proposal Overview MCB Real Estate, a well-known developer in the commercial real estate sector, has made headlines recently with its acquisition proposal for Whitestone REIT. The proposed buyout included a cash offer of $15.00 per share, aimed at delivering a substantial premium to shareholders. MCB highlighted that this offer represented a 14.5%...

Continue Reading
Year-End Cash Dividend Announced for Mexico Equity Fund

Updated Category News Views 111

Year-End Cash Dividend Announced for Mexico Equity Fund The Mexico Equity and Income Fund, Inc. has recently set an exciting precedent for its shareholders by declaring a year-end cash dividend. This decision, made by the Fund’s Board of Directors, reflects a commitment to delivering value and returns to its investors. Details of the Cash Dividend The announced dividend...

Continue Reading
Emerging Trends in Altcoins: Navigating the Crypto Landscape

Updated Category News Views 168

Rising Speculation in Altcoins: An Overview Recent activities in the altcoin sector indicate a significant increase in leveraged positions, particularly with Ethereum and other notable altcoins. This surge has raised eyebrows in the crypto community, as analysts caution about potential fragility within the market, even as Bitcoin shows signs of relative stability....

Continue Reading